Stanley W. Peters III - Feb 25, 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
VP GM Advanced Surgery
Signature
/s/ Sarah M. Oliker for Stanley W. Peters III by Power of Attorney
Stock symbol
CNMD
Transactions as of
Feb 25, 2022
Transactions value $
-$1,144,947
Form type
4
Date filed
2/28/2022, 04:05 PM
Previous filing
Feb 9, 2022
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $108K +2.7K +4285.71% $39.87 2.76K Feb 25, 2022 Direct
transaction CNMD Common Stock Sale -$400K -2.7K -97.72% $148.00 63 Feb 25, 2022 Direct
transaction CNMD Common Stock Options Exercise $335K +8K +12698.41% $41.93 8.06K Feb 25, 2022 Direct
transaction CNMD Common Stock Sale -$952K -6.42K -79.6% $148.36 1.65K Feb 25, 2022 Direct F1
transaction CNMD Common Stock Sale -$236K -1.58K -96.17% $149.36 63 Feb 25, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -2.7K -100% $0.00* 0 Feb 25, 2022 Common Stock 2.7K $39.87 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -8K -24.24% $0.00 25K Feb 25, 2022 Common Stock 8K $41.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.93. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $149.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.